ESR1 and breast cancer: A ChIP-seq and gene microarray analysis of the ZR-75-1 luminal breast cancer cell line proved that in the presence of higher concentration of one ligand (DHT versus estradiol) over the other could lead to either an increase or decrease in the ER/AR transcriptional activity [76].